Asia Pacific Pharmaceutical Contract Research Organization Market
Asia Pacific pharmaceutical CRO market will grow by 9.6% annually with a total addressable market ... Read More
Table of Contents 1 Introduction 6 1.1 Industry Definition and Research Scope 6 1.1.1 Industry Definition 6 1.1.2 Research Scope 7 1.2 Research Methodology 10 1.2.1 Overview of Market Research Methodology 10 1.2.2 Market Assumption 11 1.2.3 Secondary Data 11 1.2.4 Primary Data 11 1.2.5 Data Filtration and Model Design 13 1.2.6 Market Size/Share Estimation 14 1.2.7 Research Limitations 15 1.3 Executive Summary 16 2 Market Overview and Dynamics 19 2.1 Market Size and Forecast 19 2.1.1 Impact of COVID-19 on World Economy 20 2.1.2 Impact of COVID-19 on the Market 23 2.2 Major Growth Drivers 25 2.3 Market Restraints and Challenges 30 2.4 Emerging Opportunities and Market Trends 33 2.5 Porter’s Fiver Forces Analysis 37 3 Segmentation of Europe Market by Service 41 3.1 Market Overview by Service 41 3.2 CRO for Pre-clinical Development 43 3.3 CRO for Phase I Trials 44 3.4 CRO for Phase II Trials 45 3.5 CRO for Phase III Trials 46 3.6 CRO for Phase IV Trials 47 3.7 Laboratory Services 48 3.8 Consulting Services 49 3.9 Data Management Services 50 4 Segmentation of Europe Market by Therapeutic Application 51 4.1 Market Overview by Therapeutic Application 51 4.2 Infectious Diseases 53 4.3 Oncology 54 4.4 Metabolic Disorders 55 4.5 Cardiovascular Disorders 56 4.6 Central Nervous System 57 4.7 Respiratory Disorders 58 4.8 Gastrointestinal Disorders 59 4.9 Other Therapeutic Applications 60 5 Segmentation of Europe Market by End User 61 5.1 Market Overview by End User 61 5.2 Pharmaceutical & Biopharmaceutical Companies 63 5.3 Medical Device Companies 64 5.4 Academic Institutes 65 6 European Market 2019-2030 by Country 67 6.1 Overview of European Market 67 6.2 Germany 70 6.3 UK 72 6.4 France 75 6.5 Spain 77 6.6 Italy 79 6.7 Russia 81 6.8 Rest of European Market 83 7 Competitive Landscape 85 7.1 Overview of Key Vendors 85 7.2 New Product Launch, Partnership, Investment, and M&A 89 7.3 Company Profiles 90 Charles River Laboratories 90 CMIC Co. Ltd 92 Covance Inc. 93 Hangzhou Tigermed Consulting Co Ltd 94 ICON Plc 95 IQVIA Holdings Inc. 96 LSK Europe Pharma Service Co Ltd 97 Novotech Pty Ltd 98 PAREXEL International Corporation 99 Pharmaceutical Product Development LLC (PPD) 100 PRA Health Sciences Inc. 101 Quanticate Ltd 102 Samsung Bioepis Co. Ltd 103 SGS SA (SGS Life Sciences) 104 Syneos Health Inc. 105 WuXi AppTec Inc. 106 8 Investing in Europe Market: Risk Assessment and Management 107 8.1 Risk Evaluation of Europe Market 107 8.2 Critical Success Factors (CSFs) 110 Related Reports and Products 113
Table 1. Snapshot of Europe Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 17 Table 2. Growth Rate of World Real GDP, 2017-2021 21 Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27 Table 4. Worldwide Total Number of Registered Clinical Trials 29 Table 5. Main Product Trends and Market Opportunities in Europe Pharmaceutical CRO Market 33 Table 6. Europe Pharmaceutical CRO Market by Service, 2019-2030, $ bn 41 Table 7. Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 51 Table 8. Europe Pharmaceutical CRO Market by End User, 2019-2030, $ bn 61 Table 9. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn 69 Table 10. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn 71 Table 11. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 71 Table 12. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn 71 Table 13. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn 74 Table 14. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 74 Table 15. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn 74 Table 16. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn 76 Table 17. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 76 Table 18. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn 76 Table 19. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn 78 Table 20. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 78 Table 21. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn 78 Table 22. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn 80 Table 23. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 80 Table 24. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn 80 Table 25. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 82 Table 26. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 82 Table 27. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 82 Table 28. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn 84 Table 29. Breakdown of Europe Market by Key Vendor, 2019, % 87 Table 30. Charles River Laboratories: Company Snapshot 90 Table 31. Charles River Laboratories: Business Segmentation 90 Table 32. Charles River Laboratories: Product Portfolio 91 Table 33. Charles River Laboratories: Revenue, 2016-2018, $ bn 91 Table 34. Charles River Laboratories: Recent Developments 91 Table 35. Risk Evaluation for Investing in Europe Market, 2019-2030 108 Table 36. Critical Success Factors and Key Takeaways 111
Figure 1. Research Method Flow Chart 10 Figure 2. Breakdown of Primary Research 12 Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14 Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16 Figure 5. Europe Pharmaceutical CRO Market, 2019-2030, $ bn 19 Figure 6. Impact of COVID-19 on Business 23 Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical CRO Market 25 Figure 8. Primary Restraints and Impact Factors of Europe Pharmaceutical CRO Market 30 Figure 9. Investment Opportunity Analysis 34 Figure 10. Porter’s Fiver Forces Analysis of Europe Pharmaceutical CRO Market 37 Figure 11. Breakdown of Europe Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 42 Figure 12. Europe Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%) 42 Figure 13. Europe Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 43 Figure 14. Europe Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 44 Figure 15. Europe Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 45 Figure 16. Europe Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 46 Figure 17. Europe Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 47 Figure 18. Europe Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 48 Figure 19. Europe Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 49 Figure 20. Europe Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 50 Figure 21. Breakdown of Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 52 Figure 22. Europe Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%) 52 Figure 23. Europe Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 53 Figure 24. Europe Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 54 Figure 25. Europe Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 55 Figure 26. Europe Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 56 Figure 27. Europe Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 57 Figure 28. Europe Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 58 Figure 29. Europe Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 59 Figure 30. Europe Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 60 Figure 31. Breakdown of Europe Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 62 Figure 32. Europe Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%) 62 Figure 33. Europe Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 63 Figure 34. Europe Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 64 Figure 35. Europe Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 65 Figure 36. Breakdown of European Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue 68 Figure 37. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 69 Figure 38. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn 70 Figure 39. Pharmaceutical CRO Market in UK, 2019-2030, $ bn 72 Figure 40. Pharmaceutical CRO Market in France, 2019-2030, $ bn 75 Figure 41. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn 77 Figure 42. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn 79 Figure 43. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn 81 Figure 44. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn 83 Figure 45. Growth Stage of Europe Pharmaceutical CRO Industry over the Forecast Period 85
Key Players (this may not be a complete list and extra companies can be added upon request): Charles River Laboratories CMIC Co. Ltd Covance Inc. Hangzhou Tigermed Consulting Co Ltd ICON Plc IQVIA Holdings Inc. LSK Global Pharma Service Co Ltd Novotech Pty Ltd PAREXEL International Corporation Pharmaceutical Product Development LLC (PPD) PRA Health Sciences Inc. Quanticate Ltd Samsung Bioepis Co. Ltd SGS SA (SGS Life Sciences) Syneos Health Inc. WuXi AppTec Inc.
Asia Pacific pharmaceutical CRO market will grow by 9.6% annually with a total addressable market ... Read More
Global telehealth market will reach $171.13 billion by 2030, growing by 20.5% annually over 2020- ... Read More
North America telehealth market is expected to grow by 20.0% annually in the forecast period and ... Read More
Europe telehealth market accounted for $6,185.4 million in 2019 and will grow by 18.9% annually o ... Read More